Neovasc to Present at the Leerink Partners Global Healthcare Conference
February 15 2017 - 7:00AM
PR Newswire (Canada)
NASDAQ: NVCN
TSX: NVC
VANCOUVER, Feb. 15, 2017 /CNW/ - Neovasc Inc.
("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX:
NVC) today announced that Alexei
Marko, chief executive officer, is scheduled to present at
the LEERINK Partners 6th Annual Global Healthcare
Conference on Thursday, February
16th at 9:00 am ET
at the Lotte New York Palace in New York
City.
A live audio webcast of the presentation will be available on
the Investors page of Neovasc's website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc
Reducer™, for the treatment of refractory angina which is not
currently available in the U.S. and has been available in
Europe since 2015 and the Tiara™,
for the transcatheter treatment of mitral valve disease, which is
currently under investigation in the U.S., Canada and Europe. The Company also sells a line of
advanced biological tissue products that are used as key components
in third-party medical products including transcatheter heart
valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Copyright 2017 Canada NewsWire
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Sep 2023 to Sep 2024